AU Stock MarketDetailed Quotes

BOT Botanix Pharmaceuticals Ltd

Watchlist
  • 0.450
  • +0.010+2.27%
20min DelayMarket Closed May 7 16:00 AET
879.27MMarket Cap-50.00P/E (Static)

About Botanix Pharmaceuticals Ltd Company

Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

Company Profile

SymbolBOT
Company NameBotanix Pharmaceuticals Ltd
Founded1984
MarketASX
Employees3
Fiscal Year Ends06-30
Address41 - 47 Colin Street Suite 3
CityWest Perth
CountryAustralia
Zip Code6005
Phone+61 865552945
Share RegistryAUTOMIC REGISTRY SERVICES LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000 (08) 9324 2099

Company Executives

  • Name
  • Position
  • Salary
  • Vincent Ippolito
  • Executive Chairman of the Board
  • --
  • Matthew Callahan
  • Director
  • --
  • Danny Sharp
  • Director
  • --
  • Dr. William Bosch
  • Director
  • --
  • Dr. Stewart Washer
  • Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More